跳至主要内容
临床试验/NCT04211298
NCT04211298Unknown4 期

Dexmedetomidine Versus Propofol Sedation in Flexible Bronchoscopy: A Randomized Controlled Trial

Rabin Medical Center1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2019年12月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
100
试验地点
1
主要终点
number of de-saturation events

研究概览

简要总结

The study will evaluate clinical outcomes during bronchoscopy procedures with dexmedetomidine in comparison to propofol.

The clinical outcomes that will be evaluated are: oxygen saturation, transcutaneous Pco2, blood pressure and complications

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • All patients in the age group 18 to 70 years requiring flexible bronchoscopic evaluation of the airway in the Pulmonary institute at Rabin medical center

排除标准

  • known or suspected allergy to any of the study drugs, seizure disorder, renal (with serum creatinine > 2 mg/dL) or hepatic impairment (elevated liver enzymes > 2 times normal), haemodynamic instability (bradycardia with HR < 50 bpm or hypotension with SBP < 90 mmHg), or seriously ill patients with American Society of Anesthesiologists' physical status above III

研究组 & 干预措施

Propofol

Placebo Comparator

Propofol will be used for sedation during bronchoscopy

干预措施: Propofol (Drug)

Dexmedetomidine

Active Comparator

Dexmedetomidine will be used for sedation during bronchoscopy

干预措施: Dexmedetomidine (Drug)

结局指标

主要结局

number of de-saturation events

时间窗: During the procedure

Number of events during bronchoscopy when saturation level decreased under 90%

Oxygen saturation time < 90%

时间窗: During the procedure

Total time during the procedure that the oxygen saturation was under 90%

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mordechai Kremer

Head of the pulmonary division

Rabin Medical Center

研究点 (1)

Loading locations...

相似试验